Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.
Insulin Resistance
About this trial
This is an interventional basic science trial for Insulin Resistance focused on measuring Insulin resistance, Exercise, de novo lipogenesis, NAFLD, Magnetic Resonance Spectroscopy
Eligibility Criteria
Inclusion Criteria:
- Body Mass Index < 29 kg/m2
- No regular exercise routine
- Non-smokers
- Absence of systemic and organ disease.
Exclusion Criteria:
- Hematocrit < 35 vol%
- History of claustrophobia
- Ferromagnetic implants
- Regular exercise regimen
- Not weight stable
- Any significant hematological, neurological, musculoskeletal or endocrine disease (including diabetes mellitus)
- Any significant cardiovascular condition, including confirmed CAD and prior cardiovascular events
- Taking coumadin as anticoagulant therapy.
Sites / Locations
- YCCI/YNNH Hospital Research Unit
Arms of the Study
Arm 1
Experimental
Exercise Training
Participants will engage in a single bout of elliptical exercise for 45 minutes (3X15 spaced by 5 minutes rest) at baseline. Subjects will be studied before and after this one bout to measure hepatic de novo lipogenesis. Participants will then take part in six weeks of exercise training on an elliptical trainer 3 times per week each time for 45 minutes. Hepatic de novo lipogenesis will be compared pre and post to examine wether improving muscle glucose uptake will decrease hepatic de novo lipogenesis as the glucose is taken up by muscle and not directed to the liver.